Document is current
Any future updates will be listed below
-
Authors
Chen, Cunte https://orcid.org/0000-0003-3733-9174
Liu, Siyang Maggie https://orcid.org/0000-0002-3837-0758
Chen, Yedan https://orcid.org/0000-0002-7942-5540
Ou, Qiuxiang https://orcid.org/0000-0002-2961-2057
Bao, Hua https://orcid.org/0000-0001-5774-8755
Xu, Ling https://orcid.org/0000-0002-7044-7663
Zhang, Yikai https://orcid.org/0000-0002-6851-6260
Zhang, Jia-Tao https://orcid.org/0000-0003-4302-9332
Zhong, Wenzhao https://orcid.org/0000-0002-4000-6402
Zhou, Qing https://orcid.org/0000-0002-0478-176X
Yang, Xue-Ning https://orcid.org/0000-0002-8346-2117
Shao, Yang https://orcid.org/0000-0003-4585-1792
Wu, Yi-Long https://orcid.org/0000-0002-3611-0258
Liu, Si-Yang https://orcid.org/0000-0002-5105-6421
Li, Yangqiu https://orcid.org/0000-0002-0974-4036
-
Funding
Funding for this research was provided by:
China Postdoctoral Science Foundation (2021M701422)
Guangdong Provincial Key Laboratory of Lung Cancer Translational Medicine (2017B030314120)
National Natural Science Foundation of China (82002413)
Guangdong Provincial Applied Science and Technology Research and Development Program (2016B020237006)
- License Information
-
More Information
Article History
Received: 20 April 2022
Accepted: 15 November 2022
First Online: 24 November 2022
Declarations
:
: Yi-Long Wu discloses the following personal financial interest: Consulting and advisory services, speaking engagements for Roche, AstraZeneca, Eli Lilly, Boehringer Ingelheim, Sanofi, MSD, and BMS. Yedan Chen, Qiuxiang Ou, Hua Bao and Yang Shao are the employees of Nanjing Geneseeq Techology Inc.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Guangdong Provincial People's Hospital (No. 2011713).
: Written informed consent was received from participants before inclusion in the study. Participants were identified by number, not by name.
